QurAlis Corporation
Neuro Pioneers on a Quest to Cure - QurAlis
Cambridge, United States · $135.5M raised
- Headquarters
- Cambridge, Massachusetts
- Business Model
- B2B
- Website
- quralis.com
- Total Funding
- $135.5M
- Last Round
- $88.0M Series BFeb 2023
- Rounds
- 3
About
Biotechnology company developing precision medicines for ALS and neurodegenerative diseases, founded by Harvard Medical School researchers.
Summary
QurAlis Corporation is a Biotech company based in Cambridge, United States. It has raised $135.5M in total across 3 rounds, most recently a $88.0M Series B round in Feb 2023. Investors include Sanofi Ventures, Droia Ventures and EQT AB.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...